Literature DB >> 25977987

Characterization of Recombinant Monoclonal Antibody Charge Variants Using OFFGEL Fractionation, Weak Anion Exchange Chromatography, and Mass Spectrometry.

Alyssa Neill1, Christine Nowak1, Rekha Patel1, Gomathinayagam Ponniah1, Nidia Gonzalez1, Dino Miano1, Hongcheng Liu1.   

Abstract

Recombinant monoclonal antibody charge heterogeneity has been commonly observed as multiple bands or peaks when analyzed by charge-based analytical methods such as isoelectric focusing electrophoresis and cation or anion exchange chromatography. Those charge variants have been separated by some of the above-mentioned methods and used for detailed characterization. The utility of a combination of OFFGEL fractionation and weak anion exchange chromatography to separate the charge variants of a recombinant monoclonal antibody was demonstrated in the current study. Charge variants were separated into various fractions of high purity and then analyzed thoroughly by liquid chromatography mass spectrometry. Analysis of intact molecular weights identified the presence of heavy chain leader sequence, C-terminal lysine, and C-terminal amidation. The identified modifications were further localized into different regions of the antibody from analysis of antibody fragments obtained from FabRICATOR digestion. Analysis of tryptic peptides from various fractions further confirmed the previously identified modifications in the basic variants. Asparagine deamidation and aspartate isomerization were identified in acidic fractions from analysis of tryptic peptides. Basic variants have been fully accounted for by the identified modifications. However, only a portion of the acidic variants can be explained by deamidation and isomerization, suggesting that additional modifications are yet to be identified or acidic variants are an ensemble of molecules with different structures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25977987     DOI: 10.1021/acs.analchem.5b01452

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  10 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 2.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 3.  Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components

Authors:  Fatemeh Torkashvand; Behrouz Vaziri
Journal:  Iran Biomed J       Date:  2017-04-20

4.  LC-MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity.

Authors:  Sumit Kumar Singh; Deepak Kumar; Himanshu Malani; Anurag S Rathore
Journal:  Sci Rep       Date:  2021-01-29       Impact factor: 4.379

5.  Identification and quantitation of hinge cysteinylation on endogenous IgG2 antibodies from human serum.

Authors:  Luladey Ayalew; Alicia D D'Souza; Yan Chen; Michael T Kim
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

6.  Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study.

Authors:  Busra Gurel; Melike Berksoz; Eda Capkin; Ayhan Parlar; Meltem Corbacioglu Pala; Aylin Ozkan; Yılmaz Capan; Duygu Emine Daglikoca; Meral Yuce
Journal:  Pharmaceutics       Date:  2022-07-28       Impact factor: 6.525

7.  Identification, characterization and control of a sequence variant in monoclonal antibody drug product: a case study.

Authors:  Anushikha Thakur; Rekha Nagpal; Avik Kumar Ghosh; Deepak Gadamshetty; Sirisha Nagapattinam; Malini Subbarao; Shreshtha Rakshit; Sneha Padiyar; Suma Sreenivas; Nagaraja Govindappa; Harish V Pai; Ramakrishnan Melarkode Subbaraman
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

8.  Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry.

Authors:  Florian Füssl; Anne Trappe; Ken Cook; Kai Scheffler; Oliver Fitzgerald; Jonathan Bones
Journal:  MAbs       Date:  2018-11-11       Impact factor: 5.857

9.  Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis.

Authors:  Rachel Liuqing Shi; Gang Xiao; Thomas M Dillon; Margaret S Ricci; Pavel V Bondarenko
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

10.  Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies.

Authors:  Fengfei Ma; Fahimeh Raoufi; Marc Andre Bailly; Laurence Fayadat-Dilman; Daniela Tomazela
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.